Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/17/26 21:30 | 9/16/26 | TENX | Health | Drug | Pharmaceutical Preparations | Doogan Declan | NC | D | 1 | P.d | 102 | 1.92 | 0 | 53 | 999% | 55 | D | |||||||||||||||
9/15/26 21:38 | 9/11/26 | TENX | Health | Drug | Pharmaceutical Preparations | Giordano Christopher Thomas | NC | DO | CEO | 2 | P.dm | 40 | 2.98 | 0 | 13 | 154 | 22 | D | ||||||||||||||
9/15/26 21:30 | 9/11/26 | TENX | Health | Drug | Pharmaceutical Preparations | Staab Thomas R II | NC | O | CFO | 1 | P.d | 11 | 1.94 | 0 | 6 | 57 | 16 | D | ||||||||||||||
9/8/26 17:16 | 9/3/26 | TENX | Health | Drug | Pharmaceutical Preparations | Adar1 Capital Management, LLC | TX | T | 3 | P.m | 4,800 | 1.78 | 0 | 2,696 | 70 | 6,524 | I | |||||||||||||||
12/10/25 18:48 | 12/8/25 | TENX | Health | Drug | Pharmaceutical Preparations | Rich Stuart | NC | DO | Chief Me | 2 | P.dm | 96 | 9.64 | 0 | 10 | 377 | 13 | M | ||||||||||||||
11/20/25 18:16 | 11/17/25 | TENX | Health | Drug | Pharmaceutical Preparations | Almenoff June Sherie | NC | D | 2 | P.dm | 30 | 7.50 | 0 | 4 | 2 | I | ||||||||||||||||
11/19/25 19:01 | 11/17/25 | TENX | Health | Drug | Pharmaceutical Preparations | McGauley Thomas | NC | O | Interim | 1 | P | 58 | 7.27 | 0 | 8 | 8 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |